1National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel Ⅲ) final report [ J ]. Circulation, 2002, 106(25) : 3143 -3421. 被引量：1
2Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ guidelines [ J ]. Circulation, 2004, 110 (2) : 227 - 239. 被引量：1
3Shepherd J, Blauw G J, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER) : a randomised controlled trial [ J ]. Lancet, 2002, 360 ( 9346 ) : 1623 - 1630. 被引量：1
4Sever PS, Dahlof B, Pouher NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower - than - average cholesterol concentrations, in the Anglo - Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm ( ASCOT - LLA) : a muhicentre randomised controlled triM[ J]. Lancet, 2003, 361(9364) : 1149 -1158. 被引量：1
5Collins R, Armitage J, Parish S, et al. Effects of cholesterol - lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerehrovaseular disease or other high - risk conditions[ J ]. Lancet, 2004, 363 (9411) : 757 - 767. 被引量：1
6Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid - lowering therapy on progression of coronary atherosclerosis : a randomized controlled trial [ J ]. JAMA, 2004, 291(9) : 1071 - 1080. 被引量：1
7Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes[J]. N Engl J Med, 2004, 350(15) : 1495 -1504. 被引量：1
8Larosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease[ J]. N Engl J Med, 2005, 352(14) : 1425 -1435. 被引量：1
9Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C - reactive protein[J]. N Engl J Med, 2008, 359 (21) : 2195 - 2207. 被引量：1
10Grundy SM. The issue of statin safety-where do we stand? [J]. Circulation, 2005, 111 (23) : 3016 -3019. 被引量：1
2Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广（译）,王淑敏（译）,胡大一（校）.极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志（中文版）,2006,25(4):215-223. 被引量：345
7Stefaradis C,Toutouzas K,Vavuranakis M,et a l.Statin treatment is associated with reduced thermal heterogeneity in human atheroscle- rotic plaques[J].Eur Heart J, 2002 ( 23 ) : 1664-1669. 被引量：1
8Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP)expert panel on de- tection, evaluation and treatment of high blood cholesterol in adults (Adults Treatment Panel III)[J].JAMA, 2001 (285) : 2486-2497. 被引量：1
9Nissen S.Effect of intensive lipid lowering on progression of coronary atheroscle-rosis:evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering(REVERSAL)trial [J]. Am J Cardiol, 2005,96(5A) : 61F-68F. 被引量：1
10Dulay D, LaHaye SA, Lahey KA, et al.Efficacy of alternate day versus daily dosing of rosuvastatin[J].Can J Cardiol, 2009(25 ) : e28-e31. 被引量：1
